Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi and Proposal to Implement the World Health Organization MTB Clinical Pathway

Aim:Mycobacterium tuberculosis (MTB) is a leading cause of death worldwide. The World Health Organization (WHO) recommends X-pert MTB/RIF or X-pert Ultra as the initial test for pulmonary MTB diagnosis. While several studies have explored the cost-effectiveness of this technology, none have specific...

詳細記述

書誌詳細

出版年:	Eurasian Journal of Emergency Medicine
主要な著者:	Ward Ghaleb, Yamama Aljishi, Sanjay Ayathan, Ayesha Almemari
フォーマット:	論文
言語:	英語
出版事項:	Emergency Medicine Physicians’ Association of Turkey 2023-06-01
主題:	pulmonary mtb emergency department cost evaluation mycobacterium tuberculosis who clinical pathway x-pert mtb/rif afb smear
オンライン･アクセス:	http://eajem.com/archives/archive-detail/article-preview/cost-evaluation-of-current-pulmonary-mtb-diagnosis/60681